{
    "clinical_study": {
        "@rank": "112739", 
        "acronym": "CANON", 
        "arm_group": [
            {
                "arm_group_label": "\u03b1-lipoic acid", 
                "arm_group_type": "Active Comparator", 
                "description": "\u03b1-lipoic acid PO medication, 600mg per day, for 6weeks \u03b1-lipoic acid PO medication, 1200mg per day, for 6weeks"
            }, 
            {
                "arm_group_label": "No treatment group", 
                "arm_group_type": "No Intervention", 
                "description": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to see if it is safe and effective to give alpha lipoic acid in\n      people with cardiac autonomic neuropathy(CAN). Cardiac autonomic neuropathy(CAN) affects the\n      nerves that control heart rate and blood flow to the heart in people with diabetes. CAN may\n      cause problems with the rhythm of the heartbeat or decrease blood flow to the heart."
        }, 
        "brief_title": "The Effect of \u03b1-lipoic Acid Treatment in Patient With Cardiac Autonomic Neuropathy", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Type 2 Diabetes", 
            "Cardiac Autonomic Neuropathy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus, Type 2", 
                "Nervous System Diseases", 
                "Demyelinating Diseases", 
                "Polyneuropathies", 
                "Nerve Compression Syndromes", 
                "Neurologic Manifestations", 
                "Neurotoxicity Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "Study type : Interventional Study Design : Allocation: Randomized Control: no treatment\n      Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment\n      Masking: Open Label Primary Purpose: Treatment Primary Outcome Measures : Heart rate\n      variability(HRV) Index\n\n      Secondary Outcome Measures : Autonomic Nerve System(ANS) function 5 test, EuroQoL\n      5-Dimension Questionnaire(EQ-5D)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria :\n\n          -  Established Cardiac Autonomic Neuropathy in type 2 diabetes.\n\n          -  aged 20 years to 80 years\n\n          -  Capable of giving informed consent\n\n        Exclusion Criteria :\n\n          -  History of other significant disease such as the nerve system (Parkinson's disease,\n             epilepsy, multiple sclerosis), hepatic disease, hypothyroid, etc Other medical\n             condition or treatment likely to affect the autonomic nerve system\n\n          -  HbA1C > 11%\n\n          -  Not controlled hypertension (SBP\u2265160mmHg, DBP\u2265100mmHg)\n\n          -  Diagnosed ketoacidosis within 4 weeks\n\n          -  Unstable cardiac disease (unstable angina or myocardial infarction )\n\n          -  Pregnancy\n\n          -  Involvement in other clinical trial in last 4 weeks\n\n          -  Known or suspected sensitivity to trial products"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "91", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02056366", 
            "org_study_id": "ALA_IIT01"
        }, 
        "intervention": {
            "arm_group_label": "\u03b1-lipoic acid", 
            "description": "\u03b1-lipoic acid 600mg PO medication,Per day, For 6weeks \u03b1-lipoic acid 1200mg PO medication,Per day, For 6weeks", 
            "intervention_name": "\u03b1-lipoic acid", 
            "intervention_type": "Drug", 
            "other_name": "Neuropaid OD Tablet"
        }, 
        "intervention_browse": {
            "mesh_term": "Thioctic Acid"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Cardiac Autonomic Neuropathy", 
        "lastchanged_date": "February 4, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "137-701"
                    }, 
                    "name": "The Catholic University of Korea"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Eulji General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Sejong General Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of \u03b1-lipoic Acid Treatment in Patient With Cardiac Autonomic Neuropathy by Comparing the Change of HRV Index & ANS Function:A 6month Multicenter, Randomized, Open Label Clinical Trial CANON Study", 
        "other_outcome": {
            "description": "Check the Number of Adverse events", 
            "measure": "Number of Patients with Adverse events as a Measure of Safety", 
            "safety_issue": "Yes", 
            "time_frame": "up to 24weeks"
        }, 
        "overall_official": {
            "affiliation": "The Catholic University of Korea", 
            "last_name": "Bong Yun Cha, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "check the Heart rate variability(HRV) Index", 
            "measure": "Primary Efficacy of \u03b1-lipoic Acid  in patients with cardiac autonomic neuropathy", 
            "safety_issue": "No", 
            "time_frame": "up to 24weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02056366"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Catholic University of Korea", 
            "investigator_full_name": "Chong Hwa Kim", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Check the Autonomic Nerve System(ANS) function 5 test", 
            "measure": "Secondary Efficacy of \u03b1-lipoic Acid  in patients with cardiac autonomic neuropathy", 
            "safety_issue": "No", 
            "time_frame": "up to 24weeks"
        }, 
        "source": "The Catholic University of Korea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Catholic University of Korea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}